BD announced the global commercial launch of what it's calling the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput.
BD SpectralFX Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time. BD CellView Image Technology enables high-speed fluorescent and label-free imaging of single cells, revealing spatial and morphological insights – like the location of a virus or protein within a single cell, or the microscopic interaction between two cells – that can be visually confirmed and analyzed in real time.
"The BD FACSDiscover A8 Cell Analyzer signals an exciting step forward for researchers in areas like immuno-oncology that require tools delivering excellent reproducibility and performance, while managing budget constraints," said Rui Gardner, head of Flow Cytometry Core Facility at Memorial Sloan Kettering Cancer Center, an early access collaboration site. "Our investigators have already learned so much using this new technology, and we look forward to performing deep immunophenotyping for high-fidelity biomarker discovery to elucidate insights that can advance research and improve human health."
